Multiple Chemokine Receptors, Including CCR6 and CXCR3, Regulate Antigen-Induced T Cell Homing to the Human Asthmatic Airway1
暂无分享,去创建一个
[1] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[2] C. Guillén,et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. , 2007, The Journal of allergy and clinical immunology.
[3] R. Djukanović,et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[4] T. Means,et al. Membrane‐bound eotaxin‐3 mediates eosinophil transepithelial migration in IL‐4‐stimulated epithelial cells , 2006, European journal of immunology.
[5] R. Clark,et al. Response to Comment on “The Vast Majority of CLA+ T Cells Are Resident in Normal Skin” , 2006, The Journal of Immunology.
[6] W. Luttmann,et al. The course of allergen-induced leukocyte infiltration in human and experimental asthma. , 2006, The Journal of allergy and clinical immunology.
[7] C. Lilly,et al. Invariant natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.
[8] D. Voehringer,et al. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system , 2006, The Journal of experimental medicine.
[9] B. Medoff,et al. STAT1 in Peripheral Tissue Differentially Regulates Homing of Antigen-Specific Th1 and Th2 Cells1 , 2006, The Journal of Immunology.
[10] R. Clark,et al. The Vast Majority of CLA+ T Cells Are Resident in Normal Skin1 , 2006, The Journal of Immunology.
[11] G. Berry,et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.
[12] G. Joos,et al. Animal models of allergen‐induced tolerance in asthma: are T‐regulatory‐1 cells (Tr‐1) the solution for T‐helper‐2 cells (Th‐2) in asthma? , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[13] J. de Blic,et al. Invariant natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.
[14] J. Wain,et al. Pathogenic T‐Cell Recruitment into the Airway in Human Disease , 2005, Annals of the New York Academy of Sciences.
[15] I. Pavord,et al. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] I. Pavord,et al. IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. , 2005, The Journal of allergy and clinical immunology.
[17] S. Bromley,et al. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics , 2005, Nature Immunology.
[18] E. Butcher,et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues , 2005, Nature Immunology.
[19] S. Eisenbarth,et al. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. , 2005, The Journal of clinical investigation.
[20] W. Luttmann,et al. Chemokine‐receptor expression on T cells in lung compartments of challenged asthmatic patients , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[21] J. Tyner,et al. Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[22] W. Busse,et al. Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.
[23] A. Musani,et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)‐β1, TGF‐β2, interleukin (IL)‐4 and IL‐13 after segmental allergen challenge and their effects on α‐smooth muscle actin and collagen III synthesis by primary human lung fibroblasts , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] P. Panina-Bordignon,et al. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells , 2004, European journal of immunology.
[25] E. Butcher,et al. Chemokines in the systemic organization of immunity , 2003, Immunological reviews.
[26] J. Strominger,et al. CD1d-Restricted NKT Cells Express a Chemokine Receptor Profile Indicative of Th1-Type Inflammatory Homing Cells 1 , 2003, The Journal of Immunology.
[27] Lung-Chi Chen,et al. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. , 2003, American journal of respiratory cell and molecular biology.
[28] C. Herrick,et al. To respond or not to respond: T cells in allergic asthma , 2003, Nature Reviews Immunology.
[29] James J. Campbell,et al. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. , 2003, Journal of hepatology.
[30] I. Pavord,et al. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. , 2002, The Journal of allergy and clinical immunology.
[31] G. Tsujimoto,et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. , 2002, Blood.
[32] B. Medoff,et al. IFN-γ-Inducible Protein 10 (CXCL10) Contributes to Airway Hyperreactivity and Airway Inflammation in a Mouse Model of Asthma1 , 2002, The Journal of Immunology.
[33] F. Ronchese,et al. Differential T Cell Function and Fate in Lymph Node and Nonlymphoid Tissues , 2002, The Journal of experimental medicine.
[34] F. Spertini,et al. CXCR3 Internalization Following T Cell-Endothelial Cell Contact: Preferential Role of IFN-Inducible T Cell α Chemoattractant (CXCL11)1 , 2001, The Journal of Immunology.
[35] N. Lukacs. Role of chemokines in the pathogenesis of asthma , 2001, Nature Reviews Immunology.
[36] F. Re,et al. Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* , 2001, The Journal of Biological Chemistry.
[37] S. Lira,et al. Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.
[38] N. Krug,et al. Cytokine Profile of Bronchoalveolar Lavage–Derived CD4+, CD8+, and γδ T Cells in People with Asthma after Segmental Allergen Challenge , 2001 .
[39] E. Israel,et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.
[40] R. Breuer,et al. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. , 2001, American journal of respiratory cell and molecular biology.
[41] L. Fabbri,et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. , 2001, The Journal of clinical investigation.
[42] A. Tager,et al. Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.
[43] James J. Campbell,et al. Expression of Chemokine Receptors by Lung T Cells from Normal and Asthmatic Subjects1 , 2001, The Journal of Immunology.
[44] K. Chung,et al. Allergen-Specific Th1 Cells Counteract Efferent Th2 Cell-Dependent Bronchial Hyperresponsiveness and Eosinophilic Inflammation Partly Via IFN-γ1 , 2001, The Journal of Immunology.
[45] D. Chaplin,et al. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. , 1999, The Journal of clinical investigation.
[46] Hellman,et al. Increased levels of IL‐5 positive peripheral blood eosinophils and lymphocytes in mild asthmatics after allergen inhalation provocation , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[47] A. Bellini,et al. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation , 1998, Clinical and experimental immunology.
[48] S. Holgate,et al. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. , 1997, American journal of respiratory and critical care medicine.
[49] Third Expert Panel on theDiagnosis,et al. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .
[50] W. Luttmann,et al. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. , 1996, The European respiratory journal.
[51] P. Howarth,et al. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. , 1996, American journal of respiratory cell and molecular biology.
[52] J. Virchow,et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. , 1995, American journal of respiratory and critical care medicine.
[53] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[54] A. McLean,et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms , 1992, Nature.
[55] Phillips Yy,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.
[56] R. Crystal,et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.
[57] E. Corey,et al. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. , 1983, Journal of immunology.